<SEC-DOCUMENT>0001493152-21-001161.txt : 20210115
<SEC-HEADER>0001493152-21-001161.hdr.sgml : 20210115
<ACCEPTANCE-DATETIME>20210115161605
ACCESSION NUMBER:		0001493152-21-001161
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20210115
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210115

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Enveric Biosciences, Inc.
		CENTRAL INDEX KEY:			0000890821
		STANDARD INDUSTRIAL CLASSIFICATION:	SEMICONDUCTORS & RELATED DEVICES [3674]
		IRS NUMBER:				954484725
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38286
		FILM NUMBER:		21532302

	BUSINESS ADDRESS:	
		STREET 1:		4851 TAMIAMI TRAIL N, SUITE 200
		CITY:			NAPLES
		STATE:			FL
		ZIP:			34103
		BUSINESS PHONE:		239-302-1707

	MAIL ADDRESS:	
		STREET 1:		4851 TAMIAMI TRAIL N, SUITE 200
		CITY:			NAPLES
		STATE:			FL
		ZIP:			34103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMERI Holdings, Inc.
		DATE OF NAME CHANGE:	20150527

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SPATIALIZER AUDIO LABORATORIES INC
		DATE OF NAME CHANGE:	19950323
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: Black"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: Black"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt; color: Black"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt; color: Black"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; color: Black"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt; color: Black"><B>FORM
8-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>Current
Report</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>Pursuant
to Section 13 or 15(d) of the</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>Securities
Exchange Act of 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>Date
of Report (Date of earliest event reported): January 15, 2021</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt; color: Black"><B>ENVERIC
BIOSCIENCES, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>(Exact
name of Registrant as specified in its charter)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>Delaware</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>001-38286</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>95-4484725</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>(State
                                         or other jurisdiction</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>of
        incorporation)</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>(Commission</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>File
        No.)</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>(IRS
                                         Employer</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>Identification
        No.)</B></FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>Enveric
Biosciences, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>4851
Tamiami Trail N, Suite 200</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>Naples,
FL 34103 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>(Address
of principal executive offices and zip code)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>Registrant&rsquo;s
telephone number, including area code: (239) 302-1707</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>(Former
name or former address, if changed since last report.)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Title
    of each class</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Trading
    Symbol(s)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Name
    of each exchange on which registered</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Common
    stock, par value $0.01 per share</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">ENVB</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The
    Nasdaq Stock Market</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Emerging
growth company [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: Black"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: Black"></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>Item
8.01 Other Events.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">On
January 15, 2021, Enveric Biosciences, Inc. issued a press release announcing the closing of the previously announced registered
direct offering. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>Item
9.01 Financial Statements and Exhibits.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">(d)
Exhibits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>Exhibit</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>No.
        </B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>Description</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">99.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><A HREF="ex99-1.htm">Press Release, dated January 15, 2021</A></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: Black"><B>ENVERIC
    BIOSCIENCES INC.</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Date:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">January
    15, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">By:
    </FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><I>/s/
    John Van Buiten</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">John
    Van Buiten</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Chief
    Financial Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="height: 71px; width: 300px"></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Enveric
Biosciences Inc. Announces Closing of $10 Million Registered Direct Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NAPLES,
Fla. &ndash; January 15, 2021 &ndash; Enveric Biosciences, Inc. (NASDAQ: ENVB) (&ldquo;Enveric&rdquo; or the &ldquo;Company&rdquo;),
</B>a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients,
today announced the closing on January 14, 2021, of its $10 million registered direct offering consisting of <FONT STYLE="background-color: white">the
purchase and sale of 2,221,358 shares of Enveric&rsquo;s common stock and common stock equivalents, at a purchase price of $4.5018
per share. Also, Enveric has issued to the investors unregistered warrants to acquire 1,666,019 shares of Common Stock at $4.9519
per share, exercisable immediately and terminating five years after the date of issuance.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net proceeds to Enveric from the offering after deducting financial advisory fees and other costs and expenses were approximately
$9 million. Enveric intends to use the net proceeds from this offering for working capital and general corporate purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Palladium
Capital Group, LLC acted as a financial advisor to the issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of common stock (but not the warrants or the shares of common stock underlying the warrants) were offered by Enveric pursuant
to a &ldquo;shelf&rdquo; registration statement on Form S-3 (File No. 333-233260) previously filed with the Securities and Exchange
Commission (the &ldquo;SEC&rdquo;) on August 14, 2019, and declared effective by the SEC on November 19, 2019. The offering of
the securities (other than the warrants and the shares of common stock underlying the warrants) was made only by means of a prospectus,
including a prospectus supplement, forming a part of the effective registration statement. The final prospectus supplement and
accompanying prospectus relating to the shares of common stock being offered were filed with the SEC. Electronic copies of the
final prospectus supplement and accompanying prospectus can be obtained on the SEC&rsquo;s website at <U>http://www.sec.gov</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
warrants described above were offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the
&ldquo;Act&rdquo;), and Regulation D promulgated thereunder and, along with the shares of common stock underlying the warrants,
have not been registered under the Act, or applicable state securities laws. Accordingly, the warrants and underlying shares of
common stock may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable
exemption from the registration requirements of the Act and such applicable state securities laws. Enveric has agreed to register
the shares of common stock issuable upon exercise of the warrants for resale pursuant to a customary registration rights agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be
any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior
to the registration or qualification under the securities laws of any such state or other jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Enveric Biosciences</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enveric
Biosciences is a patient-first biotechnology company developing rigorously tested, novel, cannabinoid medicines to improve quality
of life for cancer patients. Initial indications include radiodermatitis, a common and often severe side effect of radiation therapy,
and chemotherapy-induced neuropathy. For more information, please visit <U>https://www.enveric.com/</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release contains forward-looking statements and forward-looking information within the meaning of applicable securities
laws. These statements relate to future events or future performance. All statements other than statements of historical fact
may be forward-looking statements or information. Generally, forward-looking statements and information may be identified by the
use of forward-looking terminology such as &ldquo;plans&rdquo;, &ldquo; expects&rdquo; or &ldquo;does not expect&rdquo;, &ldquo;proposed&rdquo;,
&ldquo;is expected&rdquo;, &ldquo;budgets&rdquo;, &ldquo;scheduled&rdquo;, &ldquo;estimates&rdquo;, &ldquo;forecasts&rdquo;, &ldquo;intends&rdquo;,
&ldquo;anticipates&rdquo; or &ldquo;does not anticipate&rdquo;, or &ldquo;believes&rdquo;, or variations of such words and phrases,
or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be
achieved. Forward-looking statements consist of statements that are not purely historical, including any statements regarding
beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements are based on the beliefs of management
as well as assumptions made by and information currently available to management. Actual results could differ materially from
those contemplated by the forward-looking statements as a result of certain factors, including, but not limited to, the impact
of the novel coronavirus (COVID-19) on Enveric&rsquo;s ongoing and planned clinical trials; the geographic, social and economic
impact of COVID-19 on Enveric&rsquo;s ability to conduct its business and raise capital in the future when needed; delays in planned
clinical trials; the ability to establish that potential products are efficacious or safe in preclinical or clinical trials; the
ability to establish or maintain collaborations on the development of therapeutic candidates; the ability to obtain appropriate
or necessary governmental approvals to market potential products; the ability to obtain future funding for developmental products
and working capital and to obtain such funding on commercially reasonable terms; Enveric&rsquo;s ability to manufacture product
candidates on a commercial scale or in collaborations with third parties; changes in the size and nature of competitors; the ability
to retain key executives and scientists; and the ability to secure and enforce legal rights related to Enveric&rsquo;s products,
including patent protection. A discussion of these and other factors, including risks and uncertainties with respect to Enveric,
is set forth in Enveric&rsquo;s registration statement on Form S-4 filed on May 28, 2020, as amended. Enveric disclaims any intention
or obligation to revise any forward-looking statements, whether as a result of new information, future events or otherwise, except
as required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Contacts</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valter
Pinto / Allison Soss</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">KCSA
Strategic Communications</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">212.896.1254
/ 212.896.1267</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>EnvericBio@kcsa.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Media
Contacts</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Caitlin
Kasunich / Raquel Cona</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">KCSA
Strategic Communications</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">212.896.1241
/ 516.779.2630</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>EnvericBio@kcsa.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #( TT# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **1F5%+,0J@9))P *\R\7_$0MYFGZ')@?=DNQW]D_Q_+U
MH.O!X*KBZG)37J^B/3%D1V95=69>& .2/K3J\9^&4DB^+\!SB6!P_/WNAY_$
M5[-0:9C@OJ=;V7-?1,****#@"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K"\4>(D\/Z>&4![J7(A0]/
M=C["MVO)/'=R]SXHGC)RD"+&OY9/ZDUG4ERQN>CEF%CB,0HSV6K.>O;RYU&[
M>ZNY6EF<\LW\AZ"J^VI=M&VN3F/MHVBK+8BVT;:EVT;:.8=SI/A\,>*H_P#K
MD_\ *O6Z\G\ #'BA/^N3_P J]8KJHN\3Y#/'_M7R7ZA1116IXP4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5X_P"+ESXJO_\ ?7_T$5[!7D7BT?\ %4WW^^/_ $$5SXEVBCVLC_CR
M]/U1@[:-M2XHQ7%S'U-R+;1MJ7%&*.8+G1> QCQ.G_7)_P"5>J5YCX"@D?Q
M954[(X6W'TSP*].KNP_P'R6=.^)^2_4****W/)"BBB@ HHHH **** "BBB@
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M'_O77_?P?X4?\(%H_P#>NO\ OX/\*P_^$]U7_GWL_P#OAO\ XJC_ (3W5?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK!U[Q+!I2M##MENR/N]D]V
M_P *B<XP7-)FE*E.K+D@KLO:MK%KH]OYEPV7/W(U^\Q_P]Z\UU?6;O6;CS+A
ML1K]R)?NK_\ 7]Z@N[J>^N&N+F1I)&ZD_P OI4&*\FOBG4=EHCZ?!8"&'7,]
M9=_\AF*,4_%&*YN8]"XS%&*?BC%',%QF*,4_%&*.8+C,48I^*,4<P7-_P5D>
M(5QWB;-=EXI_Y%J]_P!T?^A"N/\ !@_XJ%/^N;?RKL/$_P#R+=[_ +H_]"%>
MGAW_ +/+YGS^._W^'_;OYGE>*,4_%&*\SF/H+C,48I^*,4<P7&8I0A9@J@DD
MX '>K%K:3WMPD%O&TDC=%%>AZ!X8@TH+//MEN_[W9/I_C6]&C*J]-CDQ>-IX
M:/O:OHC*\/>#@NV[U1 3U2W/;W;_  KM    !@"BBO7ITHTU:)\MB,34Q$^:
M;_X 4445H8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4$X&3THKGO%%OJMW
M#'!8(6@;/FA6 )] <]JBI/DBY)7-:--5)J+=O-E#7_%H7=:Z8^6Z/..@]E_Q
MKBVW,Q9B2Q.23WK7_P"$9UC_ )\7_P"^E_QH_P"$9UC_ )\7_P"^E_QKQ*KK
MU97E%_<SZ;#_ %;#QY827WK4Q\48K8_X1G6/^?%_^^E_QH_X1G6/^?%_^^E_
MQK+V57^5_<;_ %FC_.OO1CXHQ6Q_PC.L?\^+_P#?2_XT?\(SK'_/B_\ WTO^
M-'LJO\K^X/K-'^=?>C'Q1BM.XT+4[6(RS6<BH.2PYQ]<5GXJ)*47:2L:1J1F
MKQ=QF*,4_%&*GF*N,Q1BGXHQ1S!<W?!HQX@3_KFU=?XF_P"1<O/]T?\ H0KD
MO!X_XGZ?]<VKLM=MY;O1;F"!"\CJ JCOR*];":X:5O,\#'M+&P;\OS/*\48K
M8_X1G6/^?%_^^E_QI5\,:PQ ^Q,/JZC^M>=[*K_*_N/9^LT?YU]Z,;%7]*T:
MZU:X\N!<(/OR-]U1_C[5T%AX)F=@]_,J)WCCY8_CT'ZUV%K:P65NL%O&L<:]
M *ZZ&"G)WJ:(X,5FD(+EHZO\%_F5=)T>UTBW\N!<N?ORM]YO_K>U:%%%>O&*
MBK+8^>G.4Y.4G=L****9(4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5YAKEO';:W=11+M0/D =LC/]:]/KS?Q&/\ BH+O
M_>'_ *"*\S--*2?F>KE#?M9+R_4R,48I^*,5X?,?07&8HQ3\48HY@N;?A ?\
M3Y/^N;5Z#7 >$A_Q/5_ZYM7?U[^6.]#YL^<S7^/\D%%%%>@>:%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%5=1U
M*RTBQDO=0N8[:VC&6DD. /\ $^U %JBO'M<^.]I#(\6AZ8]SC@3W+;%/N%')
M'U(KDY_C;XME?*#3X1_=2 G_ -"8ULJ$V9.M!'T;17S;_P +H\8?\]K/_P !
MQ1_PNCQA_P ]K/\ \!Q3^KS%[>)])45\V_\ "Z/&'_/:S_\  <4?\+H\8?\
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M:?\ 01A_\!H_\*/^%P^-/^@C#_X#1_X5],UA>+_#-OXL\.7&ESX5V&^"0_\
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M I:O!8"GA8Z:RZO^MD3B<5.N]=%V"BBBN\Y0HHHH *\(^/?_ "'-(_Z]G_\
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MO\SZD]SWJW652?/*YI"'*K!1114%A1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
'!1110!__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
